Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 3/20 | 0.42 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | PTPRS | Q13332 | 1/20 | 0.42 |
| ▸ | MMP12 | P39900 | 1/20 | 0.39 |
| ▸ | MMP13 | P45452 | 1/20 | 0.39 |
| ▸ | MCHR1 | Q99705 | 7/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | STAT5B | P51692 | 1/20 | 0.34 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.34 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.33 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3470074 | 0.89 | STAT3 (0.43) | STAT3PTPN2PTPN1PTPRSMMP12 | |
| SCHEMBL3469957 | 0.85 | PTPN2 (0.40) | STAT3PTPN2PTPN1PTPRSMMP12 | |
| SCHEMBL3466770 | 0.78 | MMP13 (0.45) | STAT3PTPN2PTPN1PTPRSMMP12 | |
| SCHEMBL3467263 | 0.77 | PTPN2 (0.39) | STAT3PTPN2PTPN1PTPRSMMP12 | |
| SCHEMBL3467062 | 0.76 | MMP13 (0.43) | STAT3PTPN2PTPN1PTPRSMMP12 | |
| SCHEMBL1860371 | 0.73 | STAT5B (0.41) | STAT5BPTGER1 | |
| SCHEMBL1855850 | 0.72 | STAT5B (0.40) | STAT5B | |
| SCHEMBL3465873 | 0.72 | MMP13 (0.42) | STAT3PTPN2PTPN1PTPRSMMP12 | |
| SCHEMBL4927290 | 0.71 | SIRT2 (0.48) | STAT3 | |
| SCHEMBL1855996 | 0.70 | STAT5B (0.36) | MMP13STAT5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010070076-A1 | ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS | CRYSTAX PHARMACEUTICALS, S.L. (ES) | 2010-06-24 | — | — | WO | disclosed |